| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/06/2005 | US20050000791 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2530376A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1493732A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2005 | EP1493057A1 Colour photographic recording material |
| 01/05/2005 | EP1492782A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 01/05/2005 | EP1492767A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | CN1561336A Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1183094C Method for stabilizing N-oxyl compound in vinyl compound |
| 01/04/2005 | US6838561 2-substituted-4-amino-phenol derivative compounds providing good oxidative coloration of hair and acceptable light fastness, fastness to shampooing and permanent wave treatment |
| 01/04/2005 | US6838527 Polymer-immobilized α-iminoester |
| 01/04/2005 | US6838471 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 01/04/2005 | US6838470 Antiischemic agents; brain disorders; cardiovascular disorders |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/04/2005 | CA2148827C Novel 3,3-diphenylpropylamines, their use and preparation |
| 01/04/2005 | CA2147155C Amide derivatives |
| 01/04/2005 | CA2093076C 2- and 3-amino and azido derivatives of 1,5-iminosugars |
| 01/02/2005 | WO2006125451A1 Hydroxyalkylamides |
| 01/02/2005 | CA2530195A1 Hydroxyalkylamides |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040266825 Using impurity as marker for stability of paroxetine hydrochloride; quantitative analysis |
| 12/30/2004 | US20040266824 Central nervous system disorders, drug abuse, obesity |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266821 Obesity, diabetes, sexual dysfunction |
| 12/30/2004 | US20040266818 Histone deacetylase inhibitors; antiproliferative agents; autoimmune, allergic and inflammatory diseases; central nervous system disorders; potency, bioavailability |
| 12/30/2004 | US20040266784 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266781 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 12/29/2004 | WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 12/29/2004 | WO2004113312A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/29/2004 | WO2004113298A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/29/2004 | WO2004113297A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2004 | WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same |
| 12/29/2004 | WO2004113280A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 12/29/2004 | WO2004112729A2 Dual function compounds and uses thereof |
| 12/29/2004 | WO2004112704A2 Substituted piperidine compounds and methods of their use |
| 12/29/2004 | WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 12/29/2004 | WO2004086050A3 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/29/2004 | WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors |
| 12/29/2004 | WO2004043380A3 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1491531A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| 12/29/2004 | EP1490336A1 Piperidine or 8-aza-bicyclo(3.2.1)oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5) |
| 12/29/2004 | EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 12/29/2004 | EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 12/29/2004 | EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators |
| 12/29/2004 | EP1285917B1 Process for producing carbostyril derivative |
| 12/29/2004 | EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/29/2004 | EP0941092B1 Use of nk-1 receptor antagonists for treating major depressive disorders |
| 12/29/2004 | CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists |
| 12/29/2004 | CN1557945A Preparation of lactams from aliphatic alpha , omega -dinitiles |
| 12/29/2004 | CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 12/29/2004 | CN1182116C Mutilin derivatives and their use as antibacterials |
| 12/29/2004 | CN1182115C 4-formyl amino-N-methylpiperidine derivatives., its application as stabilizer and stabilized organic substance therewith |
| 12/29/2004 | CN1182114C Piperazine derivatives used as CCR5 antagonist |
| 12/29/2004 | CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient |
| 12/29/2004 | CA2534094A1 Glycosidase inhibitors and methods of synthesizing same |
| 12/29/2004 | CA2529524A1 Substituted piperidine compounds and methods of their use |
| 12/29/2004 | CA2528927A1 Process for preparing 3-aminothienopyridone derivatives |
| 12/29/2004 | CA2528538A1 Dual function compounds and uses thereof |
| 12/29/2004 | CA2528317A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/29/2004 | CA2528316A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/28/2004 | US6835841 Asymmetric catalytic hydrogenation process for preparation of chiral cyclic β-aminoesters |
| 12/28/2004 | US6835840 Process for the preparation diaryl-4-amino-piperidinyl compounds |
| 12/28/2004 | US6835839 Method for the production of biperiden II |
| 12/28/2004 | US6835371 Diagnostic and therapeutic piperazine and piperidine compounds and process |
| 12/28/2004 | CA2240329C Improved delivery of multiple doses of medications |
| 12/23/2004 | WO2004111032A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 12/23/2004 | WO2004111025A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase |
| 12/23/2004 | WO2004111021A1 Cyclic hydroxylamine as psychoactive compounds |
| 12/23/2004 | WO2004111003A1 Amide derivatives as selective serotonin re-uptake inhibitors |
| 12/23/2004 | WO2004111002A1 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide |
| 12/23/2004 | WO2004111001A1 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosylceramide synthase (gcs) |
| 12/23/2004 | WO2004111000A2 Piperidyl derivatives and their use as tachykinin antagonists |
| 12/23/2004 | WO2004110996A1 Nk1 antagonist |
| 12/23/2004 | WO2004110994A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 12/23/2004 | WO2004110993A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/23/2004 | WO2004110444A1 Neurocyte protective agent |
| 12/23/2004 | WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/23/2004 | WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 12/23/2004 | WO2004055010A3 Cyclopropyl compounds as ccr5 antagonists |
| 12/23/2004 | US20040259919 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders |
| 12/23/2004 | US20040259914 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259868 Serine protease inhibitors |
| 12/23/2004 | US20040259866 Calcium channel blockers comprising two benzhydril moieties |